Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 2.978.554,41 ₫, with a 24-hour trading volume of 17,73T ₫. The asset's market cap is 7,35P ₫, after moving -0.02% in the last day.
Tokenized Merck & Co Inc is trading at 2.992.956,81 ₫, with a tokenized market cap of 22,43B ₫ and a 24-hour trading volume of 26,39B ₫. The tokenized asset has moved -0.10% in the past 24 hours.